Optiver Holding
TNGX icon

Optiver Holding’s Tango Therapeutics TNGX Stock Holding History

Optiver Holding’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.8K Buy
793
+383
+93% +$9.47K ﹤0.01% 1430
2026
Q1 		$8.58K Sell
410
-166
-29% -$2.31K ﹤0.01% 1256
2025
Q4 		$5.1K Sell
576
-38
-6% -$327 ﹤0.01% 1357
2025
Q3 		$5.16K Buy
+614
New +$4.16K ﹤0.01% 1713

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Optiver Holding's TNGX Position: Q2 2026 in Review

Optiver Holding increased its Tango Therapeutics (TNGX) stake by 93% in Q2 2026, buying an estimated $9.47K and bringing the position to 793 shares worth $24.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1430.

Optiver Holding first reported a position in TNGX in Q3 2025 and has held it in 4 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Optiver Holding held 793 shares of Tango Therapeutics worth $24.8K as of Q2 2026.
  • Optiver Holding bought 383 Tango Therapeutics shares in Q2 2026, an estimated $9.47K.
  • Tango Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1430 holding.
  • Optiver Holding first reported a position in Tango Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.